| # | Drug | Count |
|---|---|---|
| 0 | NUSINERSEN | 524 |
| 1 | BACLOFEN | 54 |
| 2 | NATALIZUMAB | 50 |
| 3 | METHOTREXATE | 44 |
| 4 | METHOTREXATE SODIUM | 44 |
| 5 | TOFERSEN | 35 |
| 6 | ERGOCALCIFEROL | 32 |
| 7 | FENTANYL | 29 |
| 8 | CYCLOPHOSPHAMIDE | 28 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NUSINERSEN | 524 | 0.0664 |
| 1 | TOFERSEN | 35 | 0.0617 |
| 2 | 1.1% SODIUM FLUORIDE PRESCRIPTION DENTAL CREAM | 1 | 0.0060 |
| 3 | ACETYLSALICYCLIC ACID | 1 | 0.0034 |
| 4 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 26 | 0.0034 |
| 5 | ZICONOTIDE ACETATE | 7 | 0.0029 |
| 6 | BUPIVACAINE | 26 | 0.0028 |
| 7 | DANTROLENE SODIUM | 3 | 0.0026 |
| 8 | CLOFARABINE | 5 | 0.0022 |
| 9 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 5 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Antisense Oligonucleotide [EPC] | 524 |
| 1 | Survival Motor Neuron-2-directed RNA Interaction [EPC] | 524 |
| 2 | Corticosteroid [EPC] | 63 |
| 3 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 57 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 47 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 45 |
| 6 | Opioid Agonist [EPC] | 42 |
| 7 | Amide Local Anesthetic [EPC] | 36 |
| 8 | Benzodiazepine [EPC] | 30 |
| 9 | Alkylating Drug [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antisense Oligonucleotide [EPC] | 524 | 0.0439 |
| 1 | Benzothiazole [EPC] | 3 | 0.0013 |
| 2 | Asparagine-specific Enzyme [EPC] | 12 | 0.0009 |
| 3 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 57 | 0.0006 |
| 4 | Barbiturate [EPC] | 5 | 0.0004 |
| 5 | Interleukin-1 Receptor Antagonist [EPC] | 7 | 0.0004 |
| 6 | Amide Local Anesthetic [EPC] | 36 | 0.0004 |
| 7 | Oxytocic [EPC] | 1 | 0.0003 |
| 8 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 9 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |